| Year |
Citation |
Score |
| 2009 |
Tobe BT, Kitazono AA, Garcia JS, Gerber RA, Bevis BJ, Choy JS, Chasman D, Kron SJ. Morphogenesis signaling components influence cell cycle regulation by cyclin dependent kinase. Cell Division. 4: 12. PMID 19566963 DOI: 10.1186/1747-1028-4-12 |
0.64 |
|
| 2002 |
Kitazono AA, Tobe BT, Kalton H, Diamant N, Kron SJ. Marker-fusion PCR for one-step mutagenesis of essential genes in yeast. Yeast (Chichester, England). 19: 141-9. PMID 11788969 DOI: 10.1002/Yea.806 |
0.486 |
|
| 2001 |
Rua D, Tobe BT, Kron SJ. Cell cycle control of yeast filamentous growth. Current Opinion in Microbiology. 4: 720-7. PMID 11731325 DOI: 10.1016/S1369-5274(01)00274-0 |
0.644 |
|
| 2001 |
Ahn SH, Tobe BT, Fitz Gerald JN, Anderson SL, Acurio A, Kron SJ. Enhanced cell polarity in mutants of the budding yeast cyclin-dependent kinase Cdc28p. Molecular Biology of the Cell. 12: 3589-600. PMID 11694591 DOI: 10.1091/Mbc.12.11.3589 |
0.504 |
|
| 2001 |
Choy JS, Tobe BT, Huh JH, Kron SJ. Yng2p-dependent NuA4 histone H4 acetylation activity is required for mitotic and meiotic progression. The Journal of Biological Chemistry. 276: 43653-62. PMID 11544250 DOI: 10.1074/Jbc.M102531200 |
0.606 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Singec I, Crain AM, Hou J, Tobe BT, Talantova M, Winquist AA, Doctor KS, Choy J, Huang X, La Monaca E, Horn DM, Wolf DA, Lipton SA, Gutierrez GJ, Brill LM, et al. Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling. Stem Cell Reports. PMID 27569059 DOI: 10.1016/j.stemcr.2016.07.019 |
0.235 |
|
| 2013 |
Tobe BT, Brandel MG, Nye JS, Snyder EY. Implications and limitations of cellular reprogramming for psychiatric drug development. Experimental & Molecular Medicine. 45: e59. PMID 24232258 DOI: 10.1038/Emm.2013.124 |
0.211 |
|
| 2012 |
Tobe BT, Hou J, Crain AM, Singec I, Snyder EY, Brill LM. Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives. Stem Cell Reviews. 8: 16-31. PMID 22009073 DOI: 10.1007/s12015-011-9317-8 |
0.19 |
|
| 2011 |
Tobe BT, Snyder EY, Nye JS. Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells. Current Opinion in Pharmacology. 11: 521-7. PMID 21723195 DOI: 10.1016/J.Coph.2011.05.007 |
0.141 |
|
| 2013 |
Hou J, Tobe BT, Lo F, Blethrow JD, Crain AM, Wolf DA, Snyder EY, Singec I, Brill LM. Combined total proteomic and phosphoproteomic analysis of human pluripotent stem cells. Methods in Molecular Biology (Clifton, N.J.). 1029: 163-89. PMID 23756949 DOI: 10.1007/978-1-62703-478-4_12 |
0.125 |
|
| 2012 |
Soman P, Tobe BT, Lee JW, Winquist AA, Singec I, Vecchio KS, Snyder EY, Chen S. Three-dimensional scaffolding to investigate neuronal derivatives of human embryonic stem cells. Biomedical Microdevices. 14: 829-38. PMID 22767243 DOI: 10.1007/S10544-012-9662-7 |
0.121 |
|
| 2014 |
Das S, Tobe B, Jain PA, Niles W, Winquist A, Mastrangelo L, Snyder EY. The Application and Future of Neural Stem Cells in Regenerative Medicine Translational Regenerative Medicine. 403-413. DOI: 10.1016/B978-0-12-410396-2.00029-3 |
0.059 |
|
| 2020 |
Pernia CD, Tobe BT, O'Donnell RC, Snyder EY. The evolution of stem cells, disease modeling, and drug discovery for neurological disorders. Stem Cells and Development. PMID 32024446 DOI: 10.1089/scd.2019.0217 |
0.039 |
|
| Hide low-probability matches. |